Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies

Clinical Transplantation

Volumn 20, Issue 5, 2006, Pages 624-633

  Jain, Ashok ^a   Ryan, Charlotte ^a   Mohanka, Ravi ^a   Orloff, Mark ^a   Abt, Peter ^a   Romano, Joan ^a   Bryan, Leah ^a   Batzold, Pam ^a   Mantry, Parvez ^a   Bozorgzadeh, Adel ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute cellular rejection; C4d; CD4; CD56; CD8; Hepatitis C recurrence; Humoral rejection; Immunohistochemistry; Liver biopsy

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; POLYCLONAL ANTIBODY; TACROLIMUS; VIRUS RNA;

ACUTE GRAFT REJECTION; ADULT; ANAMNESIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; NONHUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; PILOT STUDY; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD56; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT C4B; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS;

EID: 33748675049     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00528.x     Document Type: Article

References (36)

1. Abdelmalek MF, Firpi RJ, Soldevila-Pico C et al. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004: 10: 199.
2. Mukherjee S, Lyden E, McCashland TM, Schafer DF. Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients. J Gastroenterol Hepatol 2005: 20: 198.
3. Neff GW, O'Brien CB, Cirocco R et al. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing. Liver Transpl 2004: 10: 595.
4. Regev A, Molina E, Moura R et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004: 10: 1233.
5. Hashimoto E, Lindor KD, Homburger HA et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993: 68: 1049.
6. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 1992: 67: 1447.
7. Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol 1984: 4: 262.
8. Fiore G, Angarano I, Caccetta L et al. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroenterol Hepatol 1997: 9: 491.
9. Liaw YF, Lee CS, Tsai SL et al. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995: 22: 1368.
10. Aita K, Yamaguchi Y, Shimizu T et al. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries. Clin Transplant 2004: 18 (Suppl. 11): 7.
11. Jeong HJ, Kim SH, Kim YS, Kim SI, Kim MS, Park KI. Peritubular capillary C4d deposition in chronic allograft dysfunction. Yonsei Med J 2004: 45: 859.
12. Kanetsuna Y, Yamaguchi Y, Horita S, Tanabe K, Toma H. C4d and/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation. Clin Transplant 2004: 18 (Suppl. 11): 13.
13. Kuypers DR, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003: 76: 102.
14. Regele H, Exner M, Watschinger B et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001: 16: 2058.
15. Behr TM, Feucht HE, Richter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999: 18: 904.
16. Poelzl G, Ullrich R, Huber A et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 2005: 18: 313.
17. Magro CM, Pope Harman A, Klinger D et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant 2003: 3: 1143.
18. Miller GG, Destarac L, Zeevi A et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant 2004: 4: 1323.
19. S awada T, S himizu A, K ubota K, F uchinoue S, T eraoka S. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005: 19: 110.
20. Dankof A, Schmeding M, Morawietz L et al. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch 2005: 447: 87.
21. Krukemeyer MG, Moeller J, Morawietz L et al. Description of B-lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004: 78: 65.
22. Van Den Heuvel MC, Slooff MJ, Visser L et al. Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology 2001: 33: 1387.
23. Jain AB, Eghtesad B, Venkataramanan R et al. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl 2002: 8: 1007.
24. J ain A, D emetris AJ, K ashyap R et al. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1048 liver transplantations with a mean follow-up of 6years. Liver Transpl 2001: 7: 623.
25. Banner BF, Allan C, Savas L, Baker S, Barnard G, Bonkovsky HL. Inflammatory markers in chronic hepatitis C. Virchows Arch 1997: 431: 181.
26. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC. Immunobiology of hepatitis C virus (HCV) infection: The role of CD4 T cells in HCV infection. Immunol Rev 2000: 174: 90.
27. Imada K, Fukuda Y, Koyama Y et al. Naive and memory T cell infiltrates in chronic hepatitis C: Phenotypic changes with interferon treatment. Clin Exp Immunol 1997: 109: 59.
28. Leroy V, Vigan I, Mosnier JF et al. Phenotypic and functional characterization of intrahepatic T-lymphocytes during chronic hepatitis C. Hepatology 2003: 38: 829.
29. Torbenson M,Wang J, Abraham S, Maitra A, Boitnott J. Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol 2003: 27: 1454.
30. Baldwin WMIII, Kasper EK, Zachary AA, Wasowska BA, Rodriguez ER. Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004: 4: 311.
31. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999: 10: 2208.
32. Koo DD, Roberts IS, Quiroga I et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004: 78: 398.
33. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002: 13: 242.
34. Poduval RD, Kadambi PV, Josephson MA et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005: 79: 228.
35. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002: 13: 2371.
36. Koller H, Steurer W, Mark W et al. Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: A report of three cases. Transpl Int 2004: 17: 177.